Retinoic acids and dexamethasone alter cell-surface density of beta 2-integrins and ICAM-1 on human leukemic (HMC-1) mast cells.
Babina
M
M
Department of Dermatology, Virchow-Klinikum, Humbolt-Universität zu Berlin, Germany.
Weber
S
S
Henz
B M
BM
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D015703:Antigens, CD / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D000970:Antineoplastic Agents / Q000494:pharmacology*; D018821:CD18 Antigens / Q000032:analysis; D003907:Dexamethasone / Q000494:pharmacology*; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000032:analysis; D007938:Leukemia / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D008407:Mast Cells / Q000187:drug effects / Q000276:immunology; D014212:Tretinoin / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D000276:Adjuvants, Immunologic; D000893:Anti-Inflammatory Agents; D015703:Antigens, CD; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D018821:CD18 Antigens; D018799:Intercellular Adhesion Molecule-1; D014212:Tretinoin; D003907:Dexamethasone